The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4

Akihito Kubo, Kazuhiko Nakagawa, Ravi K. Varma, Nicholas K. Conrad, Jin Quan Cheng, Wen Ching Lee, Joseph R. Testa, Bruce E. Johnson, Frederic J. Kaye, Michael J. Kelley

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4'. Together they form a unique fingerprint.

Medicine & Life Sciences